PARKINSON DISEASE (Disorder)

Neurology
3
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AskBio
AskBioNC - Durham
1 program
1
Prescriptive Infusion AlgorithmPhase 21 trial
Active Trials
NCT07215403Not Yet Recruiting12Est. Mar 2028
Bayer
BayerLEVERKUSEN, Germany
1 program
1
Prescriptive Infusion AlgorithmPhase 2
Serina Therapeutics
Serina TherapeuticsHUNTSVILLE, AL
1 program
1
SER-252Phase 11 trial
Active Trials
NCT07422675RecruitingEst. Jan 2027

Trial Timeline

Clinical trial activity over time

2026
2027
2028
AskBioPrescriptive Infusion Algorithm
Serina TherapeuticsSER-252

Clinical Trials (2)

Total enrollment: 12 patients across 2 trials

NCT07215403AskBioPrescriptive Infusion Algorithm

Prescriptive Infusion Algorithm (PIA)

Start: May 2026Est. completion: Mar 202812 patients
Phase 2Not Yet Recruiting

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Start: Feb 2026Est. completion: Jan 2027
Phase 1Recruiting

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 12 patients
3 companies competing in this space